CD133, also known as prominin-1, is a trans-membrane glycoprotein expressed in various malignancies, such as breast carcinomas, brain tumors, pancreatic cancer, non-small cell lung cancer, hepatocellular carcinoma, and ovarian cancer. The gene discussed is PROM1; the disease is hepatocellular carcinoma.